Emmaus Life Sciences Announces Positive Top-Line Results Of Its Phase 3 Clinical Trial For Sickle Cell Disease Mar 19, 2014 8:00am EDT
Emmaus Life Sciences Cancels Stock Held By AFH Holding & Advisory And Amir Heshmatpour Jul 01, 2013 8:00am EDT
Emmaus Life Sciences Wins Sweeping Summary Judgment Victory In Suit Against AFH Holding & Advisory and Amir Heshmatpour May 16, 2013 8:00am EDT
Emmaus Life Sciences Issues Statement in Response to Announcement by AFH Holding & Advisory Jan 25, 2013 3:40pm EST